Zolium

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zolium

Quick Facts: Zolium (Alprazolam)

Property Description
Active ingredient Alprazolam
Form Oral Tablet (IR and XR variations)
Pharmacological class Benzodiazepine Anxiolytic
Common use Relief of acute anxiety and panic states
Origin Synthetic Compound (Triazolo-benzodiazepine)

Zolium: Identity, Pharmacological Class, and Origin

Zolium is the trade name for the active substance Alprazolam, a potent, synthetic psychotropic drug that belongs to the triazolo-benzodiazepine pharmacological class. This classification signifies that its general purpose is to reduce overall neuronal excitability and promote calming effects in the central nervous system. Alprazolam is clinically recognized for its efficacy in rapidly modulating symptoms of high anxiety, a characteristic supported by pharmacological studies. The compound is entirely synthetic in origin and is not derived from natural sources. The overall benefit of this compound is the provision of rapid, symptomatic relief for acute anxiety states and the intense physiological arousal associated with panic, such as during an overwhelming panic attack.

Composition and Available Tablet Forms

The active ingredient in this medication is Alprazolam, which is formulated as a single-component product administered via the oral route in the physical form of a solid tablet. The core tablet composition consists solely of the active ingredient integrated within a solid excipient matrix, which includes standard pharmaceutical fillers and binders. Crucially, Alprazolam is commonly available in two distinct types of oral tablets: the Immediate-Release (IR) tablet, which is designed for rapid absorption to address immediate anxiety, and the Extended-Release (XR) tablet, which is structurally formulated to release the active substance slowly over a sustained period. The availability of both IR and XR forms is a key distinguishing factor, offering therapeutic flexibility that allows for either prompt intervention or consistent, long-duration coverage in managing severe anxiety or panic.

Regulatory References

  1. Alprazolam - StatPearls - NCBI Bookshelf
  2. Label: ALPRAZOLAM XR- alprazolam tablet, extended release - DailyMed - NIH

What side effects are possible with Zolium?

Possible Side Effects and Safety Information

This section summarizes the official safety profile for Zolium as documented by government regulatory agencies (e.g., FDA, EMA). It is not a guide for use or a complete list of all side effects.

Serious and Clinically Significant Adverse Reactions

The medicine is associated with risks that require immediate medical attention or discontinuation. These include Complex Sleep Behaviors, such as sleepwalking, sleep-driving, and other activities performed while not fully awake. Severe, sometimes life-threatening, Anaphylactic and Anaphylactoid Reactions, including angioedema (severe swelling of the face, tongue, or throat), have been documented. The drug may also cause or exacerbate Respiratory Depression and carries a risk of Worsening Depression or Suicidal Thinking, particularly in patients with pre-existing conditions.

Common Adverse Reactions

The most frequently reported adverse effects in clinical studies include Drowsiness (somnolence), Dizziness, and Headache. Other common effects include gastrointestinal issues like Diarrhea.

Regulatory Safety Restrictions and Warnings

Classification Safety Requirement
Controlled Substance Status Zolium is classified as a Schedule IV Controlled Substance, carrying risks of Abuse, Misuse, Addiction, and Physical Dependence. Treatment should be short-term, and discontinuation must be gradual to avoid withdrawal symptoms.
Specific Patient Populations A lower initial dose is required for the elderly and those with mild to moderate liver impairment due to increased sensitivity and slower drug clearance. Use is generally restricted or avoided in cases of severe liver impairment.
Co-use Limitations Co-administration with alcohol and other CNS Depressants (including opioids) is generally prohibited or requires extreme caution due to the risk of additive sedation and respiratory depression.

Note: Safety information is organized by System Organ Class (e.g., Nervous System Disorders, Psychiatric Disorders, Immune System) in official regulatory documents.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Zolium (Alprazolam) is characterized primarily by signs of Central Nervous System (CNS) depression. Documented clinical manifestations range from mild symptoms to severe, life-threatening outcomes. Presentations typically include pronounced somnolence and confusion, alongside signs such impaired coordination, diminished reflexes, and slurred speech.

The risk of severe consequences, including coma and death, is documented, especially when Zolium is taken in combination with other CNS depressants. Official regulatory warnings emphasize that co-ingestion with opioids or alcohol significantly amplifies the risk of profound sedation and respiratory depression.

Immediate medical attention is required for any suspected overdose. Emergency services must be contacted immediately if the individual exhibits extreme sleepiness, slowed or difficult breathing, collapse, or cannot be awakened.

Management is largely symptomatic and supportive, focusing on maintaining vital functions and airway patency. While Flumazenil, a specific benzodiazepine antagonist, is available, its use is carefully constrained in official guidance due to the risk of precipitating seizures, especially in certain clinical contexts. Continuous cardiorespiratory monitoring is necessary until all symptoms resolve.

Therapeutic Uses of Zolium

What Zolium Treats: Main Uses and Benefits

The information in this section focuses solely on the clinical uses and therapeutic benefits of Zolium (Alprazolam) and is based on established therapeutic clinical domains.

The medication is commonly used for the management of Anxiety Disorder and for the treatment of Panic Disorder, which includes manifestations with or without agoraphobia.


Zolium is relevant for supportive symptomatic relief across key therapeutic domains, primarily Generalized Anxiety Disorder (GAD) and Panic Disorder. It is applied in situations marked by pervasive, excessive worry or the sudden, overwhelming onset of recurrent panic attacks, contributing to easing the overall symptom load associated with these conditions. The medication helps address symptoms that create noticeable physiological strain, such as intense fear and tension that may be present during a crisis. It is generally used when short-term symptomatic assistance is needed during phases when symptoms become more noticeable, and is also relevant for patients who require sustained symptomatic assistance for chronic conditions.


Quick Fact: Relief for Acute Distress
Primary Use Domain Conditions characterized by periods of heightened symptoms
Symptom Focus Intense fear, tension, excessive worry, and symptoms related to heightened physiological activity
Therapeutic Role Provides supportive, short-term symptomatic assistance

Eligibility and Restrictions for Use

Eligibility for Zolium (Alprazolam): Official Regulatory Status

Eligibility for Zolium is defined by regulatory authorities based on established use, prohibitions, and patient-specific restrictions. The medicine must not be used by individuals with a known hypersensitivity to alprazolam or any other benzodiazepine.

Zolium is also contraindicated in patients with acute narrow-angle glaucoma and those concurrently taking specific strong CYP3A inhibitors (e.g., ketoconazole). Use is established for adults (18 years and older).

It is not recommended for pediatric patients (under 18) as safety and effectiveness have not been established. Furthermore, use is generally not recommended during pregnancy or by breastfeeding mothers due to potential risks.

Special restrictions apply to older adults (65 years and over), who must receive the lowest effective starting dose. Use is also restricted for patients with severe hepatic insufficiency or severe respiratory insufficiency due to specific physiological risks detailed in the official labeling.

What should I know about interactions with other medicines?

Zolium (which contains alprazolam) has documented interactions primarily relating to its metabolism and its effects as a central nervous system (CNS) depressant. This information is derived from official labeling for the active ingredient.

Major Interaction Classes

Interacting Product Category Interaction Effect & Classification
Opioids and other CNS Depressants Increased risk of profound sedation, respiratory depression, coma, and death. This is classified as a clinically significant interaction, often requiring avoidance or dose reduction of one or both agents.
Strong CYP3A Inhibitors Contraindicated. These drugs block the enzyme responsible for Zolium's metabolism, leading to a significant increase in its concentration and risk of serious side effects.

Specific Interacting Products

  • Contraindicated Combinations: Strong CYP3A inhibitors such as the antifungal medications ketoconazole and itraconazole are strictly avoided due to the resulting high plasma levels of alprazolam.
  • Use-with-Caution Combinations: Co-administration with opioids (e.g., oxycodone), other CNS depressants (e.g., alcohol, sedating antihistamines, muscle relaxants), and certain antibiotics (e.g., clarithromycin, erythromycin) or HIV protease inhibitors (ritonavir) requires careful monitoring and potential dosage adjustment due to increased depressant effects or altered drug levels.

Other Interacting Substances

  • Alcohol: Concomitant use with alcohol is strongly advised against due to the severe potential for enhanced CNS depressant effects, including extreme drowsiness and slowed breathing.
  • CYP3A Inducers: Medicines that induce (speed up) CYP3A, such as carbamazepine, can decrease Zolium's effectiveness by speeding up its clearance from the body.

Mechanism of Action

Allosteric Modulation of the GABA A Receptor

Zolium's action is defined by its role as a Positive Allosteric Modulator (PAM), meaning it does not activate the GABA A receptor directly but potentiates the inhibitory effect of the brain's natural neurotransmitter, GABA. By binding to a specific allosteric site on the receptor, Zolium increases the frequency of the central chloride ( Cl^-) ion channel opening, initiating the cellular cascade by reducing the frequency of action potential initiation.

Neuronal Hyperpolarization and Systemic Inhibition

The resulting influx of negatively charged chloride ions causes rapid neuronal hyperpolarization, stabilizing the nerve cell membrane and increasing its resistance to excitatory input. This molecular event leads to a reduction in the overall electrical signaling rate across key Central Nervous System pathways, especially those pathways regulating arousal, leading to a modulation of overall CNS signaling.

⏳ Mechanism-Dependent Constraints

The physiological effectiveness of Zolium is constrained by two key factors: its absolute dependence on the presence of endogenous GABA, and the risk of receptor uncoupling or tolerance with chronic use. This pharmacodynamic limitation reduces the GABA A receptor's sensitivity to modulation over time, reducing the functional potentiation capability of the receptor.

Dosage and Administration Information

How Zolium is Used: Administration Guidelines

This section outlines the standardized instructions for the use of Zolium (Alprazolam), detailing the procedures for administration, dosing, and adjustment.


Routes and Forms

Zolium is administered solely via the oral route. It is available in multiple forms, including Immediate-Release (IR) tablets (e.g., 0.25 mg to 2 mg), Extended-Release (XR) tablets (e.g., 0.5 mg to 3 mg), Orally Disintegrating Tablets (ODT), and an oral solution.

For XR tablets, the instructions specify that the tablets must be swallowed whole and must not be divided, crushed, or chewed.


Standard Dosing Regimens and Frequency

Indication & Form Starting Dose Frequency Maximum Daily Dose
Anxiety Disorder (IR/ODT) 0.25 mg to 0.5 mg 3 times daily 4 mg
Panic Disorder (IR/ODT) 0.5 mg 3 times daily 10 mg
Panic Disorder (XR) 0.5 mg to 1 mg Once daily 10 mg

Dosage increases, when necessary, are made at intervals of no less than 3 to 4 days, with an increment of no more than 1 mg per day.


Population-Specific Use and Discontinuation

Age-Group Rules: A lower starting oral dosage of 0.25 mg, two or three times daily, is recommended for geriatric patients and those with hepatic impairment due to potential increased sensitivity.

Duration and Tapering: Clinical protocols involve a gradual dosage reduction when discontinuing the medicine. The recommended reduction rate is no more than 0.5 mg every 3 days to minimize the risk of withdrawal reactions, a procedural instruction applicable to both IR and XR forms.

Recent Clinical Evidence

Zolium: Recent Clinical Evidence

Clinical research has historically focused on the role of Zolium (alprazolam) in addressing anxiety disorders, including general anxiety and panic disorder, with or without agoraphobia. Most trials are designed to evaluate changes in symptom severity over a short-term duration, typically up to 12 weeks.

Efficacy and Symptom Metrics

Studies comparing Zolium to placebo have examined its potential association with changes in specific anxiety symptom scales. Trial findings suggest that the drug may be associated with measurable symptom reduction in some participants across various anxiety and panic disorder cohorts. The onset of observed effect often occurs relatively quickly after administration, a feature frequently noted across different benzodiazepine-class compounds.

Research on Co-administration

Limited research has explored the use of Zolium as an adjunct (additional) therapy when administered alongside other treatments, such as selective serotonin reuptake inhibitors (SSRIs) for panic disorder. This research primarily tracks whether the combination regimen is associated with changes in the frequency or severity of panic attacks compared to the use of a single agent.

Safety Profile and Adverse Events

Clinical data consistently identify drowsiness and light-headedness as the most frequent adverse events reported during the initial phase of treatment. Other adverse effects noted in trials have included impaired coordination, memory issues, and fatigue. Research also confirms the potential for the development of physical dependence, emphasizing the need for gradual dose reduction when discontinuing the therapy, as outlined in study protocols and product information.

Key Studies & References

  1. Alprazolam: MedlinePlus Drug Information
  2. NICE Guideline: Generalized anxiety disorder and panic disorder in adults: management

Frequently Asked Questions (FAQ)

Common questions about Zolium (FAQ)

Q: How quickly can I expect Zolium to start working?

The immediate-release form of Zolium is quickly absorbed. According to official regulatory data, the active ingredient typically reaches its highest concentration in the bloodstream between one and two hours after administration.

Q: Can Zolium affect your mood?

Yes, official regulatory information notes a risk of worsening depression or suicidal thinking with the use of this medication. Other mood-related effects reported during postmarketing surveillance include irritability and hostility.

Q: Are there any long-term effects of taking Zolium?

The primary long-term risks documented in official warnings are the development of physical dependence, tolerance, addiction, and misuse. These risks are why the official labeling advises that the medication be used for the shortest duration necessary, and that discontinuation must be gradual to prevent withdrawal reactions.

Q: Do I need to take Zolium at a specific time of day?

The required timing depends on the specific form prescribed. The extended-release tablet instructions state that the drug is to be taken once daily in the morning. The immediate-release form is usually prescribed up to three times per day, following a regulated schedule.

Q: Can Zolium be taken with food?

Yes, the immediate-release tablet can generally be taken without regard to food. Official documentation notes that a high-fat meal may slightly increase the absorption of the extended-release form.

Q: Are there any common over-the-counter medications that interact with Zolium?

Yes, caution is required with over-the-counter medications that act as central nervous system (CNS) depressants, such as sedating antihistamines. Using Zolium with these products can result in an additive effect, increasing sedation and impairing performance.

Q: Are there certain foods or drinks I should avoid while on Zolium?

Official patient information advises against eating grapefruit or drinking grapefruit juice while taking this medication. This restriction is due to the potential for a specific interaction that can significantly increase the concentration and effects of the drug in the body.

Q: What should I do if I miss a scheduled amount of Zolium?

Official regulatory guidance outlines that if an amount is missed, it may be taken as soon as it is remembered. However, if it is almost time for the next scheduled amount, the missed amount is to be skipped and the regular schedule is to be resumed. The guidance advises against taking a double amount.

Q: Does Zolium show up on standard drug tests?

The active ingredient in Zolium, alprazolam, is a benzodiazepine and is classified as a Schedule IV Controlled Substance. As such, the substance may be detectable on specific drug screening tests.

Q: What should a person do if they suspect an accidental overdose of Zolium?

Official guidance for suspected overdose advises contacting emergency medical services or a poison control center immediately.

Q: How long does Zolium stay in your system after you stop taking it?

The mean plasma elimination half-life of the active ingredient is approximately 11.2 hours in healthy adults. This time frame can vary widely, as drug clearance is highly dependent on individual factors like age, weight, and liver function.

Q: What is the general success rate described for Zolium?

Regulatory studies do not quantify effectiveness using a single 'success rate' percentage. Instead, the drug’s potential effect is evaluated by comparing changes in anxiety and panic symptom scales between participants taking Zolium versus those taking a placebo.

Q: What is the main purpose of the black box warning on Zolium's label?

The Boxed Warning is the most serious advisory required by the FDA. Its purpose is to emphasize the risks associated with the drug, including concomitant use with opioids, and the serious potential for abuse, misuse, addiction, physical dependence, and withdrawal reactions.

Q: Are there any common supplements that should not be taken with Zolium?

Supplements that affect the CYP3A4 enzyme, such as St. John's Wort or Kava, are officially noted as requiring caution or avoidance. These products may alter the effectiveness of Zolium or increase the risk of side effects.

Q: Does Zolium work for everyone who takes it?

Clinical studies indicate that the medication may be associated with measurable symptom reduction in 'some' participants. This reflects the common observation in medicine that individual patient responses to any drug can vary.

Q: What kind of monitoring is usually required while taking Zolium?

Monitoring is generally required to assess for serious adverse effects, including respiratory depression, profound sedation, abuse, and dependence. The physician is also advised to periodically reassess the continued usefulness of the drug.

Q: Does Zolium affect blood pressure?

Yes, low blood pressure, known as hypotension, has been reported as an adverse reaction in clinical trials.

Q: Is it safe to drive or operate machinery while taking Zolium?

The official labeling explicitly cautions patients against performing activities that require complete mental alertness, such as driving a motor vehicle or operating hazardous machinery. This is due to the drug's known central nervous system depressant effects.

Q: Can I take Zolium if I have kidney issues?

Changes in drug elimination have been reported in patients with impaired renal function (kidney issues). While the official label does not mandate a specific dose adjustment, caution and close monitoring are advised due to the potential for increased sensitivity to the effects of the medication.

Q: Is there a generic version of Zolium available?

Yes, Zolium is a trade name for the active ingredient, alprazolam. Alprazolam is widely available, and regulatory agencies have approved multiple generic versions for the market.

Q: Why does the official information on Zolium mention a risk of [Specific Rare Side Effect]?

Regulatory agencies require that all observed adverse events, including those that are rare or serious, be documented in the official prescribing information. This is accomplished through postmarketing surveillance to ensure complete transparency of all potential risks associated with the drug.

Q: What is the source of the official patient information for Zolium?

The official source for detailed patient safety information is the Medication Guide, which is required by the FDA to be distributed with the prescription. Additional information is found in the full Prescribing Information intended for healthcare providers.

Q: Are there known interactions between Zolium and herbal teas?

Herbal products, including those used in teas, that affect the CYP3A4 enzyme (like St. John's Wort) or cause central nervous system depression (like Kava) are officially noted as requiring caution or avoidance. These products may interact with Zolium.

How should Zolium be stored and disposed of?

Storage and Disposal of Zolium (Alprazolam)

The requirements for the storage and disposal of Zolium are based on official regulatory labeling to maintain product quality and safety.


Storage Requirements

Zolium must be stored at Controlled Room Temperature (CRT), maintained between 20 C and 25 C (68 F and 77 F). The medication must be kept in its tightly closed, light-resistant container to protect it from moisture, heat, and direct light exposure. Due to the high risk of harm from accidental ingestion, Zolium must always be stored in a secure location and kept out of the reach of children.

Disposal Instructions

Unused or expired Zolium must be disposed of promptly according to specific regulatory guidance for controlled substances. The preferred method is to use a community drug take-back program. If a take-back program is not readily available, the FDA specifies that Zolium may be discarded by flushing the tablets down the toilet to prevent accidental exposure and misuse.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zolium found in:

A-Z Index: